dihexa hgf c-met cancer risk Hepatocyte Growth Factor/c-Met Signaling in Head and Neck and Implications for Treatment Targeting cancer-associated fibroblast-activated HGF/c-MET pathway
Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect HGF Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment PMC Correlation between hypoxia and HGF c MET expression in the management of pancreatic cancer ScienceDirect dihexa hgf c met cancer risk Role of the HGF c MET tyrosine kinase inhibitors in Molecular mechanism(s) of regulation(s) of
Pay in 4 interest-free payments of $6.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27



